Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Pulse Biosciences | PLSE | 5. nov 2024 | 16.47 | +8.43 |
PulteGroup | PHM | 5. nov 2024 | 133.26 | +2.91 |
Puma Biotechnology | PBYI | 5. nov 2024 | 2.96 | +0.34 |
Pure Cycle | PCYO | 5. nov 2024 | 11.46 | +3.71 |
Pure Storage A | PSTG | 5. nov 2024 | 51.15 | +2.88 |
PureCycle Technologies | PCT | 5. nov 2024 | 12.59 | +0.64 |
PureCycle Technologies Unit | PCTTU | 5. nov 2024 | 16.50 | -3.62 |
Purefunds ISE Junior Silver [Sm | SILJ | 5. nov 2024 | 13.37 | +0.07 |
PureTech Health ADR | PRTC | 5. nov 2024 | 21.00 | +0.82 |
Purple Biotech ADR | PPBT | 5. nov 2024 | 2.88 | -3.03 |
Purple Innovation | PRPL | 5. nov 2024 | 0.83 | -12.00 |
Putnam Managed Municipal Income Trust | PMM | 5. nov 2024 | 6.28 | 0.00 |
Putnam Master Intermediate Income Trust | PIM | 5. nov 2024 | 3.27 | -0.15 |
Putnam Municipal Opportunities Trust | PMO | 5. nov 2024 | 10.52 | +0.10 |
Putnam Premier Income Trust | PPT | 5. nov 2024 | 3.59 | +0.28 |
PVH | PVH | 5. nov 2024 | 100.00 | -0.38 |
Pyrophyte Acquisition | PHYT | 5. nov 2024 | 11.55 | 0.00 |
Pyxis Oncology | PYXS | 5. nov 2024 | 3.93 | +3.42 |
Pyxis Tankers | PXS | 5. nov 2024 | 4.34 | +0.24 |
Pyxis Tankers Pref | PXSAP | 5. nov 2024 | 24.97 | 0.00 |
Q2 | QTWO | 5. nov 2024 | 86.21 | +2.17 |
Q32 Bio | QTTB | 5. nov 2024 | 47.72 | +1.88 |
QCR | QCRH | 5. nov 2024 | 80.78 | +1.66 |
QIAGEN | QGEN | 5. nov 2024 | 43.95 | +0.69 |
Qifu Technology ADR | QFIN | 5. nov 2024 | 33.64 | +2.13 |
Qilian International | QLI | 5. nov 2024 | 5.41 | 0.00 |
QMMM | QMMM | 5. nov 2024 | 12.39 | +3.42 |
Qomolangma Acquisition | QOMO | 5. nov 2024 | 11.45 | 0.00 |
Qorvo | QRVO | 5. nov 2024 | 71.80 | +0.60 |
QT Imaging | QTI | 5. nov 2024 | 0.55 | -6.24 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.